Antileukemic Effects of Buthionine Sulfoximine (BSO) (NSC 326231) in Vivo: A Pilot Study in Acute Myeloblastic Leukemia View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2001

AUTHORS

J. Curtis , D. W. Hedley , M. D. Minden , M. A. Moore , E. A. Mcculloch

ABSTRACT

In this pilot study we have tested the in vivo effects of the potent glutathione (GSH)-depleting agent buthionine sulfoximine (BSO) on the peripheral blood blast cells of 6 patients with acute myeloblastic leukemia (AML) in relapse. The clinical trial was designed to extend the observation that in the presence of BSO the cells of some blast populations are depleted of GSH and undergo apoptosis. Each patient received a continuous intravenous infusion of BSO over 72 hours. A loading dose of 3 Gm/m2 body surface area (BSA) was given over 30 minutes followed by a continuous infusion at a rate of 0.75 Gm/m2 BSA/hour. Blood was drawn before the start of BSO, at 24,48 and 72 hours and later times after BSO to determine clonogenic cell recovery (CCR) and to measure by flow cytometry intracellular GSH and reactive oxygen intermediates (ROI). In vitro BSO dose responses were determined by exposing AML blast cells to a range of doses of BSO for 48 hours in suspension culture; cells were then washed, counted and an aliquot plated in methylcellu-lose to enable calculation of CCR. BSO levels were measured every 12 hours during the infusion of BSO. The AML continuous cell line OCI/AML-5 was used to determine the effect of BSO on resistance to cytosine arabinoside (ARA-C) in culture. For 5 patients CCR in vivo was measured serially; CCR for two patients decreased to <20% of control, for two patients to <70% and for one patient there was no change. Serial intracellular GSH values were available for 4 of these patients with reductions ranging from 32 to 45% of control. Plasma BSO levels showed patient to patient heterogeneity. Clinical status and blood counts remained stable during BSO; no significant toxicity was observed. The ARA-C resistance of OCI/AML-5 cells was reduced in the presence of BSO. More... »

PAGES

257-264

Book

TITLE

Acute Leukemias VIII

ISBN

978-3-642-62109-3
978-3-642-18156-6

Author Affiliations

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-642-18156-6_44

DOI

http://dx.doi.org/10.1007/978-3-642-18156-6_44

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011084186


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Department of Medical Oncology and Hematology, Princess Margaret Hospital and Division of Cellular and Molecular Biology, Ontario Cancer Institute, Toronto, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Curtis", 
        "givenName": "J.", 
        "id": "sg:person.01033477712.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033477712.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Department of Medical Oncology and Hematology, Princess Margaret Hospital and Division of Cellular and Molecular Biology, Ontario Cancer Institute, Toronto, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hedley", 
        "givenName": "D. W.", 
        "id": "sg:person.0766554047.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766554047.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Department of Medical Oncology and Hematology, Princess Margaret Hospital and Division of Cellular and Molecular Biology, Ontario Cancer Institute, Toronto, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Minden", 
        "givenName": "M. D.", 
        "id": "sg:person.01143512370.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143512370.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Department of Medical Oncology and Hematology, Princess Margaret Hospital and Division of Cellular and Molecular Biology, Ontario Cancer Institute, Toronto, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moore", 
        "givenName": "M. A.", 
        "id": "sg:person.016115060017.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115060017.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Department of Medical Oncology and Hematology, Princess Margaret Hospital and Division of Cellular and Molecular Biology, Ontario Cancer Institute, Toronto, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mcculloch", 
        "givenName": "E. A.", 
        "id": "sg:person.0112714202.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0112714202.22"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejm199812033392301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001055591"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/chromsci/34.7.326", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004731642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cyto.990210113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007239517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cyto.990210113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007239517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2401138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010311208", 
          "https://doi.org/10.1038/sj.leu.2401138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2401138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010311208", 
          "https://doi.org/10.1038/sj.leu.2401138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0163-7258(91)90076-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014336605"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0163-7258(91)90076-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014336605"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1996.d01-1912.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015467842"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1996.d01-1912.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015467842"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(77)92818-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019307710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(77)92818-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019307710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199410063311402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026923022"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1993.484", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047447912", 
          "https://doi.org/10.1038/bjc.1993.484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1993.484", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047447912", 
          "https://doi.org/10.1038/bjc.1993.484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.92.17.7690", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049186138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/84.4.264", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059817713"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079568316", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079996640", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079998582", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082402199", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082414870", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1995.13.3.560", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082550205"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082624062", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082639321", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1994.12.1.194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082731775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.1.249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082858563"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082887520", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082907709", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001", 
    "datePublishedReg": "2001-01-01", 
    "description": "In this pilot study we have tested the in vivo effects of the potent glutathione (GSH)-depleting agent buthionine sulfoximine (BSO) on the peripheral blood blast cells of 6 patients with acute myeloblastic leukemia (AML) in relapse. The clinical trial was designed to extend the observation that in the presence of BSO the cells of some blast populations are depleted of GSH and undergo apoptosis. Each patient received a continuous intravenous infusion of BSO over 72 hours. A loading dose of 3 Gm/m2 body surface area (BSA) was given over 30 minutes followed by a continuous infusion at a rate of 0.75 Gm/m2 BSA/hour. Blood was drawn before the start of BSO, at 24,48 and 72 hours and later times after BSO to determine clonogenic cell recovery (CCR) and to measure by flow cytometry intracellular GSH and reactive oxygen intermediates (ROI). In vitro BSO dose responses were determined by exposing AML blast cells to a range of doses of BSO for 48 hours in suspension culture; cells were then washed, counted and an aliquot plated in methylcellu-lose to enable calculation of CCR. BSO levels were measured every 12 hours during the infusion of BSO. The AML continuous cell line OCI/AML-5 was used to determine the effect of BSO on resistance to cytosine arabinoside (ARA-C) in culture. For 5 patients CCR in vivo was measured serially; CCR for two patients decreased to <20% of control, for two patients to <70% and for one patient there was no change. Serial intracellular GSH values were available for 4 of these patients with reductions ranging from 32 to 45% of control. Plasma BSO levels showed patient to patient heterogeneity. Clinical status and blood counts remained stable during BSO; no significant toxicity was observed. The ARA-C resistance of OCI/AML-5 cells was reduced in the presence of BSO.", 
    "editor": [
      {
        "familyName": "B\u00fcchner", 
        "givenName": "T.", 
        "type": "Person"
      }, 
      {
        "familyName": "Hiddemann", 
        "givenName": "W.", 
        "type": "Person"
      }, 
      {
        "familyName": "W\u00f6rmann", 
        "givenName": "B.", 
        "type": "Person"
      }, 
      {
        "familyName": "Schellong", 
        "givenName": "G.", 
        "type": "Person"
      }, 
      {
        "familyName": "Ritter", 
        "givenName": "J.", 
        "type": "Person"
      }, 
      {
        "familyName": "Creutzig", 
        "givenName": "U.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-642-18156-6_44", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-642-62109-3", 
        "978-3-642-18156-6"
      ], 
      "name": "Acute Leukemias VIII", 
      "type": "Book"
    }, 
    "name": "Antileukemic Effects of Buthionine Sulfoximine (BSO) (NSC 326231) in Vivo: A Pilot Study in Acute Myeloblastic Leukemia", 
    "pagination": "257-264", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011084186"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-642-18156-6_44"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "34cf4a56939688614d8369472076f91ba93bcf96806b5f3dc153218e58dcaa7e"
        ]
      }
    ], 
    "publisher": {
      "location": "Berlin, Heidelberg", 
      "name": "Springer Berlin Heidelberg", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-642-18156-6_44", 
      "https://app.dimensions.ai/details/publication/pub.1011084186"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T08:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000369_0000000369/records_68943_00000000.jsonl", 
    "type": "Chapter", 
    "url": "https://link.springer.com/10.1007%2F978-3-642-18156-6_44"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-18156-6_44'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-18156-6_44'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-18156-6_44'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-18156-6_44'


 

This table displays all metadata directly associated to this object as RDF triples.

180 TRIPLES      23 PREDICATES      50 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-642-18156-6_44 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N06ff3b056d424653bce95aa84cdea33b
4 schema:citation sg:pub.10.1038/bjc.1993.484
5 sg:pub.10.1038/sj.leu.2401138
6 https://app.dimensions.ai/details/publication/pub.1079568316
7 https://app.dimensions.ai/details/publication/pub.1079996640
8 https://app.dimensions.ai/details/publication/pub.1079998582
9 https://app.dimensions.ai/details/publication/pub.1082402199
10 https://app.dimensions.ai/details/publication/pub.1082414870
11 https://app.dimensions.ai/details/publication/pub.1082624062
12 https://app.dimensions.ai/details/publication/pub.1082639321
13 https://app.dimensions.ai/details/publication/pub.1082887520
14 https://app.dimensions.ai/details/publication/pub.1082907709
15 https://doi.org/10.1002/cyto.990210113
16 https://doi.org/10.1016/0163-7258(91)90076-x
17 https://doi.org/10.1016/s0140-6736(77)92818-5
18 https://doi.org/10.1046/j.1365-2141.1996.d01-1912.x
19 https://doi.org/10.1056/nejm199410063311402
20 https://doi.org/10.1056/nejm199812033392301
21 https://doi.org/10.1073/pnas.92.17.7690
22 https://doi.org/10.1093/chromsci/34.7.326
23 https://doi.org/10.1093/jnci/84.4.264
24 https://doi.org/10.1200/jco.1994.12.1.194
25 https://doi.org/10.1200/jco.1995.13.3.560
26 https://doi.org/10.1200/jco.1996.14.1.249
27 schema:datePublished 2001
28 schema:datePublishedReg 2001-01-01
29 schema:description In this pilot study we have tested the in vivo effects of the potent glutathione (GSH)-depleting agent buthionine sulfoximine (BSO) on the peripheral blood blast cells of 6 patients with acute myeloblastic leukemia (AML) in relapse. The clinical trial was designed to extend the observation that in the presence of BSO the cells of some blast populations are depleted of GSH and undergo apoptosis. Each patient received a continuous intravenous infusion of BSO over 72 hours. A loading dose of 3 Gm/m2 body surface area (BSA) was given over 30 minutes followed by a continuous infusion at a rate of 0.75 Gm/m2 BSA/hour. Blood was drawn before the start of BSO, at 24,48 and 72 hours and later times after BSO to determine clonogenic cell recovery (CCR) and to measure by flow cytometry intracellular GSH and reactive oxygen intermediates (ROI). In vitro BSO dose responses were determined by exposing AML blast cells to a range of doses of BSO for 48 hours in suspension culture; cells were then washed, counted and an aliquot plated in methylcellu-lose to enable calculation of CCR. BSO levels were measured every 12 hours during the infusion of BSO. The AML continuous cell line OCI/AML-5 was used to determine the effect of BSO on resistance to cytosine arabinoside (ARA-C) in culture. For 5 patients CCR in vivo was measured serially; CCR for two patients decreased to <20% of control, for two patients to <70% and for one patient there was no change. Serial intracellular GSH values were available for 4 of these patients with reductions ranging from 32 to 45% of control. Plasma BSO levels showed patient to patient heterogeneity. Clinical status and blood counts remained stable during BSO; no significant toxicity was observed. The ARA-C resistance of OCI/AML-5 cells was reduced in the presence of BSO.
30 schema:editor Nf765dda6763b45399ee823cc43c398cb
31 schema:genre chapter
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf Nb5c21e7d23cb4bc1b4cfe07164ab2a40
35 schema:name Antileukemic Effects of Buthionine Sulfoximine (BSO) (NSC 326231) in Vivo: A Pilot Study in Acute Myeloblastic Leukemia
36 schema:pagination 257-264
37 schema:productId N1820b25bb9954a6690db53b07a26f5c7
38 N5c69023edf3d4b748cbf6b62dd596509
39 Nf52ab8cdc4184df9ba7afbc31a98fcb9
40 schema:publisher N9f35c0163431459ba6dac7d3aea1dcfa
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011084186
42 https://doi.org/10.1007/978-3-642-18156-6_44
43 schema:sdDatePublished 2019-04-16T08:54
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N22c319dcd84e4509b94add14b3776425
46 schema:url https://link.springer.com/10.1007%2F978-3-642-18156-6_44
47 sgo:license sg:explorer/license/
48 sgo:sdDataset chapters
49 rdf:type schema:Chapter
50 N06ff3b056d424653bce95aa84cdea33b rdf:first sg:person.01033477712.10
51 rdf:rest Nb4e5dc0b8f8f46fd876e5e2d665612f3
52 N0bfc76a4b8794f1183a8f10d210996e7 rdf:first sg:person.01143512370.79
53 rdf:rest Nf103eee8c7b847898071524613fd2ff0
54 N150d2642b28c48ca906e17dcd93ec7d0 rdf:first Nbe60462ce1bf4da093779ca7838867a8
55 rdf:rest rdf:nil
56 N1820b25bb9954a6690db53b07a26f5c7 schema:name readcube_id
57 schema:value 34cf4a56939688614d8369472076f91ba93bcf96806b5f3dc153218e58dcaa7e
58 rdf:type schema:PropertyValue
59 N22c319dcd84e4509b94add14b3776425 schema:name Springer Nature - SN SciGraph project
60 rdf:type schema:Organization
61 N38778a5ea3194c47a1ab121fcc85462d schema:familyName Wörmann
62 schema:givenName B.
63 rdf:type schema:Person
64 N38a7ddc6b841483bb10196c2c5a6ee52 rdf:first Na9eeaca8b59644848ec4effc8b42492a
65 rdf:rest N150d2642b28c48ca906e17dcd93ec7d0
66 N4457a5ef95464874a7c803106a2e60dd rdf:first N38778a5ea3194c47a1ab121fcc85462d
67 rdf:rest N898bead56f7e43cdbd6e74fe6186d338
68 N4d7f11f359b247da9eafce4cc21f69ec rdf:first sg:person.0112714202.22
69 rdf:rest rdf:nil
70 N5c69023edf3d4b748cbf6b62dd596509 schema:name dimensions_id
71 schema:value pub.1011084186
72 rdf:type schema:PropertyValue
73 N6371c4a489a247ee9437a480075f586c schema:familyName Büchner
74 schema:givenName T.
75 rdf:type schema:Person
76 N842d7c922d2e4c819f5805b76260e682 rdf:first Nac9a873ab4c845f193fa8d0ad899c82d
77 rdf:rest N4457a5ef95464874a7c803106a2e60dd
78 N898bead56f7e43cdbd6e74fe6186d338 rdf:first N92f3d54e0e6c4f2b9feb1d1b369db89c
79 rdf:rest N38a7ddc6b841483bb10196c2c5a6ee52
80 N92f3d54e0e6c4f2b9feb1d1b369db89c schema:familyName Schellong
81 schema:givenName G.
82 rdf:type schema:Person
83 N9f35c0163431459ba6dac7d3aea1dcfa schema:location Berlin, Heidelberg
84 schema:name Springer Berlin Heidelberg
85 rdf:type schema:Organisation
86 Na9eeaca8b59644848ec4effc8b42492a schema:familyName Ritter
87 schema:givenName J.
88 rdf:type schema:Person
89 Nac9a873ab4c845f193fa8d0ad899c82d schema:familyName Hiddemann
90 schema:givenName W.
91 rdf:type schema:Person
92 Nb4e5dc0b8f8f46fd876e5e2d665612f3 rdf:first sg:person.0766554047.59
93 rdf:rest N0bfc76a4b8794f1183a8f10d210996e7
94 Nb5c21e7d23cb4bc1b4cfe07164ab2a40 schema:isbn 978-3-642-18156-6
95 978-3-642-62109-3
96 schema:name Acute Leukemias VIII
97 rdf:type schema:Book
98 Nbe60462ce1bf4da093779ca7838867a8 schema:familyName Creutzig
99 schema:givenName U.
100 rdf:type schema:Person
101 Nf103eee8c7b847898071524613fd2ff0 rdf:first sg:person.016115060017.96
102 rdf:rest N4d7f11f359b247da9eafce4cc21f69ec
103 Nf52ab8cdc4184df9ba7afbc31a98fcb9 schema:name doi
104 schema:value 10.1007/978-3-642-18156-6_44
105 rdf:type schema:PropertyValue
106 Nf765dda6763b45399ee823cc43c398cb rdf:first N6371c4a489a247ee9437a480075f586c
107 rdf:rest N842d7c922d2e4c819f5805b76260e682
108 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
109 schema:name Medical and Health Sciences
110 rdf:type schema:DefinedTerm
111 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
112 schema:name Oncology and Carcinogenesis
113 rdf:type schema:DefinedTerm
114 sg:person.01033477712.10 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
115 schema:familyName Curtis
116 schema:givenName J.
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033477712.10
118 rdf:type schema:Person
119 sg:person.0112714202.22 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
120 schema:familyName Mcculloch
121 schema:givenName E. A.
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0112714202.22
123 rdf:type schema:Person
124 sg:person.01143512370.79 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
125 schema:familyName Minden
126 schema:givenName M. D.
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143512370.79
128 rdf:type schema:Person
129 sg:person.016115060017.96 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
130 schema:familyName Moore
131 schema:givenName M. A.
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115060017.96
133 rdf:type schema:Person
134 sg:person.0766554047.59 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
135 schema:familyName Hedley
136 schema:givenName D. W.
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766554047.59
138 rdf:type schema:Person
139 sg:pub.10.1038/bjc.1993.484 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047447912
140 https://doi.org/10.1038/bjc.1993.484
141 rdf:type schema:CreativeWork
142 sg:pub.10.1038/sj.leu.2401138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010311208
143 https://doi.org/10.1038/sj.leu.2401138
144 rdf:type schema:CreativeWork
145 https://app.dimensions.ai/details/publication/pub.1079568316 schema:CreativeWork
146 https://app.dimensions.ai/details/publication/pub.1079996640 schema:CreativeWork
147 https://app.dimensions.ai/details/publication/pub.1079998582 schema:CreativeWork
148 https://app.dimensions.ai/details/publication/pub.1082402199 schema:CreativeWork
149 https://app.dimensions.ai/details/publication/pub.1082414870 schema:CreativeWork
150 https://app.dimensions.ai/details/publication/pub.1082624062 schema:CreativeWork
151 https://app.dimensions.ai/details/publication/pub.1082639321 schema:CreativeWork
152 https://app.dimensions.ai/details/publication/pub.1082887520 schema:CreativeWork
153 https://app.dimensions.ai/details/publication/pub.1082907709 schema:CreativeWork
154 https://doi.org/10.1002/cyto.990210113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007239517
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/0163-7258(91)90076-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014336605
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1016/s0140-6736(77)92818-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019307710
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1046/j.1365-2141.1996.d01-1912.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1015467842
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1056/nejm199410063311402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026923022
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1056/nejm199812033392301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001055591
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1073/pnas.92.17.7690 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049186138
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1093/chromsci/34.7.326 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004731642
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1093/jnci/84.4.264 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059817713
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1200/jco.1994.12.1.194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082731775
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1200/jco.1995.13.3.560 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082550205
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1200/jco.1996.14.1.249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082858563
177 rdf:type schema:CreativeWork
178 https://www.grid.ac/institutes/grid.17063.33 schema:alternateName University of Toronto
179 schema:name Department of Medical Oncology and Hematology, Princess Margaret Hospital and Division of Cellular and Molecular Biology, Ontario Cancer Institute, Toronto, Canada
180 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...